JUNE 17 (Eagle News) — The government of South Korea initiates the conducting of blood plasma experimental treatment on patients with Middle East Respiratory Syndrome coronavirus (MERS-CoV).
Said experimental treatment was formerly used on patients with Severe Acute Respiratory Syndrome and the results were positive resulting in a lessening of the death rate. (Seoul, South Korea)
(Eagle News Service Jay Paul Carlos, Jericho Morales, MRFaith Bonalos)
